ADENI LIMITED

Company number 04471259 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: ADENI LIMITED

1. Financial Health Score: C+

Explanation: The patient shows encouraging signs of recovery in the latest period, transitioning from negative to positive net worth. However, this recovery follows a pattern of chronic volatility, and underlying structural weaknesses remain. The business has survived for over 20 years, demonstrating resilience, but carries persistent conditions that make it vulnerable to external shocks.


2. Key Vital Signs

Blood Pressure — Solvency (Net Assets Position)

Year Net Assets Status
2017 £2,611 Marginal
2018 £793 ⚠️ Critical
2019 £11,137 ✅ Healthy
2020 £5,142 Moderate
2021 £(2,032) 🔴 Insolvent
2022 £(4,051) 🔴 Insolvent
2023 £2,662 Marginal
2024 £(4,680) 🔴 Insolvent
2025 £9,570 ✅ Recovering

Diagnosis: This is an irregular heartbeat pattern. The company has oscillated between solvency and insolvency multiple times, spending three of the last five years with negative net assets. While the 2025 position shows significant improvement, the historical pattern suggests this may be cyclical rather than sustained recovery.


Pulse Rate — Liquidity (Current Assets vs. Current Liabilities)

Year Current Assets Current Liabilities Working Capital
2024 £10,077 £14,607 £(4,530) 🔴
2025 £20,266 £10,546 £9,720

Interpretation: The company has moved from a position where current liabilities exceeded current assets by over £4,500 to a positive working capital position. This is a dramatic improvement — like a patient coming off critical support. However, the underlying composition of those liabilities requires closer examination.


Cholesterol — Capital Structure (Equity vs. Debt)

Component 2025 2024
Share Capital £100 £100
Retained Profits £9,470 £(4,780)
Director Loan £10,546 £9,607
Debt-to-Equity Ratio 1.10 Negative equity

Critical Finding: The share capital of just £100 is dangerously thin — this is the financial equivalent of a patient with severely low blood volume. The business is essentially running on director loan funding rather than invested equity.


Temperature — Director Loan Dependency

The director's loan account (PB Davies) tells a concerning story:

Year Director Loan Owed As % of Total Liabilities
2023 £9,332 100%
2024 £9,607 66%
2025 £10,546 100%

Interpretation: The company's liabilities are almost entirely comprised of the director's loan. This means the business is not trading with creditor debt in the traditional sense — it is operating on funds advanced by one of its owners. While this eliminates external creditor pressure, it creates a single point of vulnerability.


3. Diagnosis

Primary Condition: Chronic Under-capitalization with Cyclical Revenue Pattern

The financial data reveals a business that has been operating for over two decades with minimal equity investment. The £100 share capital has never been supplemented, meaning all business growth has been funded through retained profits (when they exist) and director loans.

Symptoms of this condition:

  1. Thin Equity Cushion: With net assets of only £9,570, even modest losses could push the company back into negative territory. This is like having minimal reserves in the immune system — any infection could become serious.

  2. Director Loan Dependency: PB Davies is effectively bankrolling the operation. The loan has grown from £9,332 to £10,546, suggesting either: - Additional funds were injected in 2025 to support the business, OR - Profits were insufficient to cover drawings, increasing the debt

  3. Volatile Earnings Pattern: The swing from -£4,680 to +£9,570 in net assets within a single year (a £14,250 improvement) suggests either: - A significant contract was won and revenue recognised - The director converted part of the loan to equity (though share capital remains £100) - Working capital management improved dramatically

  4. No Profit & Loss Visibility: As a micro-entity, the company files filleted accounts with no P&L, making it impossible to assess revenue trends, margins, or profitability directly.

Secondary Condition: Potential Cash Flow Timing Issues

The nature of the business (chartered surveyors and housing consultants) suggests project-based revenue. This can create timing mismatches between revenue recognition and cash collection, explaining the volatility in net assets year-to-year.


4. Prognosis

Short-term Outlook: Cautiously Optimistic

The 2025 recovery is genuine and significant. Net assets have more than recovered from the 2024 deficit, and the company is now in a positive equity position. Filing is up to date, and the company appears operationally active.

Medium-term Outlook: Guarded

The historical pattern of oscillation between positive and negative net assets suggests this recovery may not be permanent. Without structural changes to the capital base, the company remains vulnerable to:

  • Loss of a major client or contract
  • Economic downturns affecting the construction/housing sector
  • The director calling in the loan (though this seems unlikely given his ownership position)
  • Cash flow timing issues on large projects

Long-term Outlook: Stable but Fragile

The company has survived 20+ years with this model, suggesting a viable underlying business. However, it operates in a perpetually fragile financial state — like a patient who manages their condition but never builds robust health.


5. Recommendations

Immediate Actions (Critical Care)

  1. Capital Injection: Consider converting a portion of the director loan (£5,000-£7,000) into share capital. This would: - Strengthen the equity position substantially - Reduce the debt-to-equity ratio - Provide a more realistic capital structure for a 20-year-old business - Cost: Minimal (stamp duty at 0.5% on the amount converted)

  2. Build Cash Reserves: Retain a greater proportion of profits to build a buffer against future downturns. Target a minimum of £15,000-£20,000 in net assets for a business of this age and type.

Medium-term Actions (Rehabilitation)

  1. Revenue Diversification: As a housing consultancy and quantity surveying practice, explore: - Recurring revenue streams (retainer agreements, annual inspections) - Thermal imaging services (mentioned on website) as a differentiator - Public sector contracts for housing assessments

  2. Working Capital Management: - Implement stricter credit control procedures - Consider requiring deposits on larger projects - Review payment terms with clients to reduce the cash conversion cycle

  3. Financial Forecasting: Develop 12-month cash flow forecasts to anticipate and prevent future negative net asset positions. This is the financial equivalent of regular health monitoring.

Long-term Actions (Preventative Care)

  1. Review Profit Extraction Strategy: The director loan balance has grown over time, suggesting profits may be extracted via loan rather than dividend. Consider: - Declaring dividends when profits permit (more tax-efficient for the company) - Formalising a repayment schedule for the director loan - Setting a target to reduce the loan balance by 10-15% annually

  2. Consider Graduating from Micro-Entity Status: While micro-entity filing reduces administrative burden, it limits the financial information available to stakeholders. As the company grows, consider filing as a small company to provide: - A Profit & Loss account - More detailed balance sheet disclosures - Better transparency for potential clients or partners

  3. Succession Planning: With two directors owning 25-50% each, ensure there are clear agreements in place for: - What happens if one director wishes to exit - How the director loan would be treated in a buyout scenario - Key person insurance to protect against loss of either director


Risk Assessment Summary

Risk Factor Severity Likelihood Impact
Return to negative net assets 🔴 High Medium Insolvency risk
Director loan recall 🟡 Medium Low Immediate liquidity crisis
Client concentration 🟡 Medium Medium Revenue volatility
Sector downturn 🟡 Medium Medium Reduced revenue
Regulatory changes 🟢 Low Low Compliance costs

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 27 August 2026